Michelle Huffaker is a Rheumatology/Immunology physician affiliated with Immune Tolerance Network. OpenAlex indexes 43 publications with 489 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Pasteur Dr
Stanford, CA 943052200
Telephone
650-723-4000Provider last certified this registry record 4 Sept 2025.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Takeda Pharmaceuticals U.S.A., Inc.Program year20254 payments
- GlaxoSmithKline, LLC.Program year20231 payment
- Genentech USA, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
90.3%Corticosteroid44.4%Trelegy Ellipta46%Symbicort29%Breo Ellipta26%Part D<11 patientsHistamine-1 Receptor Antagonist20.2%Azelastine Hcl100%Part D≥13 patients+ 2 more classes in this area
Dermatology
9.7%Interleukin-4 Receptor alpha Antagonist9.7%Dupixent Pen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Novel Weekly Combined Symptom Medication Score to Assess Seasonal Allergic Rhinitis Burden and Efficacy of Immunotherapy
Journal of Allergy and Clinical Immunology
2026 - Comorbid Food and Aeroallergen Sensitization Does Not Affect Peanut Oral Immunotherapy Outcomes in Young Children
Journal of Allergy and Clinical Immunology
2026 - Durable Clinical Efficacy of Grass Pollen Sublingual Tablet Immunotherapy in Combination with Dupilumab in Adults with Seasonal Allergic Rhinitis
Journal of Allergy and Clinical Immunology
2026 - When Should Milk Be Introduced? A Question Still Worth Pouring Over
The Journal of Allergy and Clinical Immunology In Practice
2026
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”